Patent judgment introduction
- _Reiwa 2 (Ne) No. 10057 (September 2022.9.12, XNUMX) New
- Introduction to US Judgment - Limited to negative claims - (2022.7.25)
- European Intellectual Property Information Introduction – Court of Justice of the European Union (CJEU), Judgment on Patent Validity and Interim Remedies for Infringement – (2022.5.30)
- _Reiwa 104 (Ne) No. 2 (April 10059, 2022.4.4)
- Support requirements Effect-related configuration>_ Reiwa 10136 (Gyoke) No. 2021.10.11 (XNUMX)
- _Introduction of US patent precedents (2021.6.28)
- _Reiwa 2 (Gyoke) No. 10102 (2021.6.14)>
- _30 (Gyohi) No. 69 Request for rescission of trial decision (May 2021.5.17, XNUMX)
- _Introduction to US patent precedents (2021.4.19)
- _Introduction of US patent precedents (2021.04.05)
- _30 (Gyoke) No. 10076 (March 2021.3.29, XNUMX)
- _Introduction to US patent precedents (2020.11.9)
- _Introduction to US Patent Case Laws (2020.10.12)
- _31 (Gyo-ke) No. 10040 (2020.09.14)
- _Introduction of European case law (2020.8.17)
- _Reiwa 10110 (Gyoke) No. 2020.08.03 (XNUMX)
- _31 (Gyo-ke) No. 10025 (2020.07.13)
- _Introduction of US patent precedents (101)
- _Introduction to US Patent Case Laws (2020.6.15)
- _Reiwa 10100 (Gyoke) No. 2020.05.07 (XNUMX)
- _31 (Gyoke) No. 10011 (2020.04.14)
- _Heisei 102 (Ne) No. 1 (31)
- _Heisei 31 (Ne) No. 10005 (2020.02.03)
- _29 (Wa) No. 15518 (2019.10.15)
- _Patent Court 2019.3.29 Declaration 2018 Ho 2717 (2019.09.09)
- _Heisei 102 (Ne) No. 2 (3)
- 30 (Gyoke) No. 10043 (2019.08.05)
- 30 (Gyoke) No. 10036 (2019.07.08)
- 2018.11.14GB Introduction to the Supreme Court judgment (2019.04.22)
- _CN patent judgment introduction (2018.11.12)
- 29 (Ne) No. 10090 (2018.07.17)
- 28 (Gyoke) Nos. 10182 and 10184 - Pyrimidine derivative case - (2018.04.23)
- 29 (Ne) No. 10013 (2017.07.31)
- Introduction to case law regarding selected inventions 28 (Gyoke) No. 10037 - Case of "Liquid crystal composition containing polymerizable compound and liquid crystal display element using the same" case - (September 2017, 09, written by Toshiro Kuroda)
- Introduction of precedents for food-related inventions 28 (Gyoke) No. 10147 - Tomato juice case (support requirements) - (July 2017, 07 Written by: Toshiro Kuroda)
- Case law introduction: “Judgments regarding product-by-process claims” 2012 (Uke) No. 1204, No. 2658
- Regarding a case law in which the issue was whether or not there were any obstructive factors (February 2010, 02, written by Kazuki Matsumura)
- Case No. 19 of 10369 (Inventability of technical idea involving human mental activity)
- No. 18 of 10074 (Meaning of “inventor (co-inventor)” under the Patent Act)
- Supreme Court 2009 (Gyohi) No. 326 Application for registration of extension of the term of patent right Supreme Court judgment
Biointellectual property information content
- About the visa system - Enforced from 020.10.1 - (2021.5.17)New
- Examples of clearly contributing to the achievement of SDGs - Information systems field - (2021.4.5)
- (2021.1.18)
- Utilization of WIPO GREEN by research institutions such as universities - From the perspective of SDGs and ESG - (December 2020, 12)
- (2020.11.30)
- Utilization of WIPO GREEN – From the perspective of SDGs and ESG – (October 2020, 10)
- _Reiwa 10124 (Gyoke) No. 2020 (October 10, 26)
- [Intellectual property information] Application of exceptions to loss of novelty (grace period) in each country (June 2020, 06)
- COVID-19 (spread of new coronavirus infection) promotes artificial intelligence (AI)-related inventions in the fields of chemical engineering and pharmaceuticals (2020.05.19)
- Regarding the impact that the spread of infection may have on patent rights (April 2020, 04, written by Tatsuya Seki)
- Nobel Prize and patent application (April 2020, 04 Written by: Yuri Miyasaka)
- [AI registered patent case] - Cases in the chemical and bio fields (predicting the effects of test substances) - (October 2019, 10)
- USPTO publishes a collection of case studies for determining patent eligibility for nature-based materials (July 2015, 07, written by Fumihito Ashida)
- Judgment on the validity of gene patents (CAFC) (August 2011, 08, written by Toshiro Kuroda)
- Requirements for disclosing the source of genetic resources - Overview of COP2011 and the Nagoya Protocol - (January 01, 17 Written by Rio Tomono)
- Points to note in SNP (single nucleotide polymorphism) related applications (August 2010, 08 Written by: Kenjiro Fujita)
- Judgment of “Obvious to try” – Comparison of Japan and the US – (March 2010, 03, written by Toshiro Kuroda)
- Regarding the revision of examination standards for "industrially applicable inventions" and "medicinal inventions" (November 2009, 11, written by Morio Nakao)
- A study on pharmaceutical patents and drug access issues (November 2009, 11, written by Kazuya Hasegawa)
- Concerning basic patents - Green fluorescent protein (GFP) edition - (October 2009, 10, written by Kenjiro Fujita)
- About public health and compulsory patent rights (July 2009, 7, written by Mitsuko Yamaguchi)
- Research tool patent (June 2009, 6, written by Kentaro Tsuruta)
- Regarding patent protection in the advanced medical field (June 2009, 6, written by Toshiro Kuroda)
- Generic drug entry and patents - Comparison of Japan, the US, and South Korea - (April 2009, 4, written by Toshiro Kuroda)
- Defense of abuse of rights in breeder rights infringement lawsuits (July 2008, 07, written by Maiko Murahashi)
- About functional RNA (March 2008, 3, written by: Naoki Aono)
- Regarding patent protection for pharmaceuticals (February 2008, 2, written by Mitsuko Yamaguchi)
- Regarding access to genetic resources and profit sharing (January 2008, 1, written by Ichijo Matsumura)
- About the deposit system (January 2008, 1, written by Kazuya Hasegawa)
- Regarding the patent right term extension system (December 2007, 12, written by Morio Nakao)
- Comparison of systems in Japan, the United States, Europe, and China regarding medical-related inventions (December 2007, 12, written by Toshiro Kuroda)
- Regarding the protection of protein 2004D structure information, etc. (January 1, 20, written by Toshiro Kuroda)
- About human cloning (February 2003, 2, written by Cho Jeong-suk)